DWHP acquires majority stake in Belgium's Cefaly Technology
DW Healthcare Partners (DWHP) has acquired a majority stake in Cefaly Technology SPRL, a Liège, Belgium-based maker and marketer of neuro-modulating medical devices for the prevention and treatment of migraines. No financial terms were disclosed. Pierre Rigaux, who co-founded Cefaly in 2004, said the partnership with DWHP will facilitate the company's next stage of growth. With the deal, Jen Trainor was appointed CEO, replacing Rigaux. DWHP, a Toronto- and Park City, Utah-based healthcare private equity firm, said Cefaly is the inaugural investment of DW Healthcare Partners Fund V, which earlier this year raised US$610 million.
8 August 2019•3 mins read
